Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Assay and Drug Development Technologies|April 20, 2004
In vitro evolution of proteins for drug developmentSimon Delagrave, Dennis J MurphyProtein Engineering, Design & Selection : PEDS|April 12, 2005
Directed evolution of PDZ variants to generate high-affinity detection reagentsMarc Ferrer, Jim Maiolo, Patricia Kratz, et al.Virology|September 1, 2020
Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell modelMichael Kishko, John Catalan, Kurt Swanson, et al.Virology|February 17, 2007
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirusCaroline C Maier, Simon Delagrave, Zhen-xi Zhang, et al.Plos One|June 20, 2018
Effect of genetic background and delivery route on the preclinical properties of a live attenuated RSV vaccineRachel Groppo, Joshua DiNapoli, Kwang Il Jeong, et al.Plos One|March 8, 2013
High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivoSophia T Mundle, Hector Hernandez, John Hamberger, et al.Plos One|June 25, 2015
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent MannerKwang-Il Jeong, Peter A Piepenhagen, Michael Kishko, et al.Virology|November 17, 2009
Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirusAlexander A Rumyantsev, Zhen-xi Zhang, Qing-sheng Gao, et al.Cell Reports|December 21, 2022
Comprehensive profiling of antibody responses to the human anellome using programmable phage displayThiagarajan Venkataraman, Harish Swaminathan, Cesar A Arze, et al.Cell Reports. Medicine|March 15, 2023
Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccinationCarolyn M Boudreau, John S Burke, Alexander L Roederer, et al.Pageof 2